Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer
Clinical trial NCT00536939 · TERMINATED
Trial details
- NCT number
- NCT00536939
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2008-03-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.